Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.
Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials
AIDS . 27(13): 2081-2088. Nº de citas: 13
-
Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010
BMC INFECTIOUS DISEASES . 13: 382-382. Nº de citas: 18
-
Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.
Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections
CLINICAL INFECTIOUS DISEASES . 57(3): 458-464. Nº de citas: 3
-
Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.
Travel associated Diseases, Indian Ocean Islands, 1997-2010
EMERGING INFECTIOUS DISEASES . 19(8): 1297-1301. Nº de citas: 17
-
Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.
Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.
CLINICAL AND VACCINE IMMUNOLOGY . 20(8): 1197-1202. Nº de citas: 17
-
Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R.
Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment
ACTA TROPICA . 127(2): 101-104. Nº de citas: 28
-
Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.
The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients
NEPHROLOGY DIALYSIS TRANSPLANTATION . 28(8): 2073-2081. Nº de citas: 17
-
Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS . 27(11): 1771-1778. Nº de citas: 105
-
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H, BENCHMRK Study Teams.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
LANCET INFECTIOUS DISEASES . 13(7): 587-596. Nº de citas: 103
-
Casado JL.
Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine
AIDS REVIEWS . 15(3): 139-145. Nº de citas: 14
-
Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA.
Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
AIDS . 27(10): 1641-1655. Nº de citas: 6
-
Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA.
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
AIDS . 27(9): 1513-1516. Nº de citas: 107
-
Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, Cantón R, Meseguer MA.
Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 32(6): 769-772. Nº de citas: 46
-
Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J.
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus
JOURNAL OF HEPATOLOGY . 58(6): 1104-1112. Nº de citas: 22
-
Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M.
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(6): 1423-1430. Nº de citas: 38
-
Casado JL, Iglesias V, del Palacio M, Marín A, Perez-Elías MJ, Moreno A, Moreno S.
Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV . 25(12): 1599-1603. Nº de citas: 5
-
Rosinska M, Marzec-Bogustawska A, Janiec J, Smolen-Dzirba J, Wasik T, Gniewosz J, Zalewska M, Murphy G, McKinney E, Porter K, CASCADE Collaboration In Eurocoord.
High Percentage of Recent HIV Infection Among HIV-Positive Individuals Newly Diagnosed at Voluntary Counseling and Testing Sites in Poland
AIDS RESEARCH AND HUMAN RETROVIRUSES . 29(5): 805-813. Nº de citas: 19
-
Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD.
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study(a)
JOURNAL OF INFECTIOUS DISEASES . 207(9): 1359-1369. Nº de citas: 224